September 20, 2022 — Medtronic, a global leader in healthcare technology, today announced the LINQ II Insertable Cardiac Monitor (ICM) system is the first-and-only ICM to receive 510(k) clearance by ...
Implantable Cardiac Monitor (ICM)
Implantable cardiac monitors (ICM) are small electrophysiology (EP) devices that used for long-term monitoring of a patient's heart electrical activity to detect arrhythmias. The technology can eliminate the need for a bulkly external Holter monitor that requires wire leads attached to the patient. ICMs can be inserted under the skin during and office visit and record cardiac data continuously for up to 4.5 years.
-
-
April 29, 2022 – Medtronic has announced new data from the STROKE AF clinical trial, which showed that large and small vessel ischemic stroke patients who receive short-term or intermittent monitoring ... -
April 6, 2022 – Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of patients with non-ST segment elevation myocardial infarction (NSTEMI). In the ... -
February 25, 2022 – Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for the company’s CardioMEMS HF System to support the care of more people ...
January 30, 2023 — Heart disease is the leading cause of death worldwide. In the U.S., it is estimated that someone dies ...
January 30, 2023
October 6, 2022 — The complications experienced by heart failure patients implanted with a left ventricular assist ...
October 06, 2022
September 20, 2022 — Medtronic, a global leader in healthcare technology, today announced the LINQ II Insertable Cardiac ...
September 20, 2022
Feature | Heart Failure | By Jean-Luc Boulnois, Ph.D.
The current standard of care for heart failure (HF) is guideline-directed medical therapy combined with device-based ...
May 04, 2022
May 4, 2022 — More than 60 million magnetic resonance imaging (MRI) scans are performed worldwide each year, but imaging ...
May 04, 2022
April 29, 2022 – Medtronic has announced new data from the STROKE AF clinical trial, which showed that large and small ...
April 29, 2022
April 6, 2022 – Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of ...
April 06, 2022
February 25, 2022 – Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an expanded ...
February 25, 2022
January 4, 2022 – Remote patient monitoring and cardiac data management solutions vendor Implicity received U.S. Food ...
January 04, 2022
September 8, 2021 — Continuous heart rhythm monitoring – with anticoagulation if atrial fibrillation is detected – does ...
September 08, 2021
September 7, 2021 — Remote monitoring of implantable cardiac monitors (ICMs) is highly effective for early detection of ...
September 07, 2021
August 9, 2021 - In association with Heart Rhythm 2021, Biotronik today announced that the latest implantable cardiac ...
August 09, 2021
Feature | Telecardiology | Victor Wollesen
Cardiovascular diseases are among the leading causes of death for people over 65 years old in North America and Europe ...
July 23, 2021
June 13, 2021 — Medtronic announced clinical trial results from the STROKE AF trial demonstrating the superiority of the ...
July 14, 2021
July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation ...
July 01, 2021© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now